GENE ONLINE|News &
Opinion
Blog

2022-08-11| R&D

Extreme Climate Change Is Aggravating Infectious Diseases!

by GeneOnline
Share To

Severe infectious diseases have been spreading worldwide frequently in the last decade. Global climate change has been known to contribute to the increased threat of infectious diseases to humans by altering the transmission routes of pathogens, but this hypothesis has remained elusive to quantify.

A recent research paper published on August 8 in Nature Climate Change by a team of researchers from the University of Hawaiʻi at Mānoa pointed out that with global warming and the accumulation of greenhouse gas emissions, up to 58% of human infectious diseases have been at some point aggravated by climatic hazards, and that the most fundamental way of mitigation is to reduce greenhouse gas emissions.

Related Article: WHO Sounds Monkeypox Alarm as Cases Continue Rising Worldwide

Modeling Response to Various Climate Hazards and Disease Scenarios

In order to understand the systematic effects of different types of climate hazards on various infectious diseases, the research team gathered nearly 2,000 corresponding documents through a literature review of 10 types of climate hazards (e.g., warming, droughts, heat waves, floods, etc.). As for infectious disease scenarios, they used the Global Infectious Disease and Epidemiology Network (GIDEON) and the database of infectious diseases of the US Centers for Disease Control and Prevention (CDC) to list a total of 375 diseases with clear climate-related causes, including dengue fever and malaria.

Literature search strategy: The team carried out three complementary literature searches about case examples of diseases affected by climatic hazards. (Source: Nature Climate Change)
Viral and Bacterial Infectious Diseases Aggravated by Extreme Climate

According to the analysis, up to 218 out of 375 diseases (58%) were found to be aggravated by specific climate change conditions. The most common climate change events include warming, extreme precipitation, floods, and droughts, and among all affected pathogens, 76 were infectious diseases of viral origin (adenovirus, COVID-19, avian influenza virus, etc.), 69 were infectious diseases of bacterial origin (leprosy, Q fever, Vibrio vulnificus), followed by animal-borne pathogens, fungal infections, and other categories.

Specifically, the reasons for the aggravation of infectious diseases due to climate change are related to three factors: 1) the warming climate is conducive to the growth of pathogenic bacteria, which accelerates their life cycle 2) the incubation period of pathogens is shortened, increasing their exposure time to the host 3) climate suitability for reproduction and virulence of pathogens are increased (for instance, warming has positive effects on mosquito population development, survival, biting rates and viral replication, increasing the transmission efficiency of West Nile virus).

The pathways in which climatic hazards, via specific transmission types, result in the aggravation of specific pathogenic diseases (Source: Nature Climate Change)

This retrospective study quantified the association between climate change and the occurrence of infectious diseases and confirmed that many human infectious diseases are not independent events. Whether it is HIV, influenza virus, or dengue fever, the researchers have found more than 1,000 unique pathways of climate hazards that aggravate the transmission of pathogens. The paper serves not only as a reminder that adapting to diseases associated with extreme climates will become more arduous in the future but also that the fundamental solution is to reduce greenhouse gas emissions to avoid favorable conditions for the growth and transmission of pathogens.

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
CDC Calls an End to J&J’s COVID-19 Vaccine in the U.S.
2023-05-25
Avian Flu H5N1: Fear Over Potential Spread Among Humans and What We Should Know
2023-02-15
LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
EVENT
Scroll to Top